Citation:Thomas T, Abrams KR, De Caestecker JS, Robinson RJ 2007

From Cancer Guidelines Wiki

Citation


Thomas T, Abrams KR, De Caestecker JS, Robinson RJ. Meta analysis: Cancer risk in Barrett's oesophagus. Aliment Pharmacol Ther 2007 Dec;26(11-12):1465-77 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/17900269.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the incidence of neoplasia in patients with BO?Associate Professor Freddy Sitascompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

Cited by

  1. Are there groups of patients with BO that can be discharged from surveillance?
  2. Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
  3. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
  4. What is the incidence of neoplasia in patients with BO?